SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-016457
Filing Date
2021-12-23
Accepted
2021-12-22 17:33:02
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2632897
2 filename2.htm EX-10.5(A) 158557
3 filename3.htm EX-10.5(B) 6240
4 filename4.htm EX-10.5(C) 30351
5 filename5.htm EX-10.6(A) 129038
6 filename6.htm EX-10.6(B) 7912
7 GRAPHIC g241143g01q92.jpg GRAPHIC 156302
8 GRAPHIC g241143g01w95.jpg GRAPHIC 120391
9 GRAPHIC g241143g06d72.jpg GRAPHIC 123393
10 GRAPHIC g241143g22f22.jpg GRAPHIC 142227
11 GRAPHIC g241143g35m69.jpg GRAPHIC 57045
12 GRAPHIC g241143g40e22.jpg GRAPHIC 160057
13 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
14 GRAPHIC g241143g86d55.jpg GRAPHIC 166435
15 GRAPHIC g241143g92y88.jpg GRAPHIC 173723
  Complete submission text file 0000950123-21-016457.txt   4533664
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-05663 | Film No.: 211514185
SIC: 2836 Biological Products, (No Diagnostic Substances)